Basic Sildalis Information

• INN (International Nonproprietary Name): Sildalis does not have an official INN and is a combination medication containing two active pharmaceutical ingredients: sildenafil citrate (INN: sildenafil) and tadalafil (INN: tadalafil).
• Brand Names Available In Canada (English): Sildalis is marketed as a non-innovator, mostly internet-sold combination drug that merges the active ingredients of Viagra (sildenafil) and Cialis (tadalafil); it is primarily available through online pharmacies and unofficial distributors rather than registered local pharmacies.
• ATC Code: G04BE03 (sildenafil) and G04BE08 (tadalafil).
• Forms & Dosages: Sildalis tablets are typically supplied as 100 mg sildenafil + 20 mg tadalafil in blister packs (blisters of 6–20).
• Manufacturers In Canada (English): Not specified for Canada; manufacturing is mostly by Indian generic companies or direct-to-web suppliers and Sildalis is not produced by major original pharmaceutical manufacturers.
• Registration Status In Canada (English): Not registered as a combination product with major national drug agencies; there is no public record of a Health Canada DIN for Sildalis.
• OTC / Rx Classification: Prescription only (Rx) in jurisdictions where sildenafil or tadalafil are regulated, although Sildalis is often sold without a prescription through online shops outside regulated supply chains.
• Standard Dosage Per Condition: For erectile dysfunction, the marketed tablet strength is 100 mg sildenafil + 20 mg tadalafil, with one tablet taken about 30–60 minutes before sexual activity and not more than once per 24 hours.
• Dosage Adjustments: Not approved for children; elderly patients and those with liver or kidney impairment should start at the lowest effective dose and be monitored closely; Sildalis has not been specifically studied for dose reduction.
• Storage And Transport Guidelines: Store below 30°C (86°F), away from moisture and direct sunlight, and keep out of reach of children.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Patients often ask whether to take Sildalis in the morning or evening when planning around work, family or social life.

The usual instruction for the marketed product is one tablet 30–60 minutes before anticipated sexual activity, and not more than once in 24 hours.

Most Canadians find evening dosing fits social and private time better because tadalafil in the combination has a longer duration of action.

Morning dosing is less common because sildenafil has a quick onset and patients rarely need daytime coverage for longer periods.

When counselling, pharmacists discuss timing relative to planned activity rather than rigid clock times.

Taking With Or Without Meals (Canadian Diet Context)

Sildalis combines sildenafil (faster onset) and tadalafil (longer duration), so absorption considerations mainly reflect sildenafil’s profile.

High-fat meals can slow sildenafil absorption and delay onset, so heavy breakfasts like full English-style meals or late weekend poutine can reduce or delay effect.

Moderate alcohol — one or two drinks — may be tolerated but raises dizziness and hypotension risk; avoid binge drinking with any PDE5 inhibitor.

In rural communities with limited clinic hours, keeping an extra prescription or contacting a local pharmacist at Shoppers Drug Mart, London Drugs or the nearest independent pharmacy helps with safe timing advice.

• Quick Do’s: Take one tablet 30–60 minutes before activity; bring your full medication list to appointments; store tablets below 30°C.
• Quick Don’ts: Do not mix with nitrates or riociguat; avoid heavy fatty meals right before dosing; avoid excessive alcohol.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Sildalis contains sildenafil and tadalafil and should be treated as a combination of those prescription medicines when assessing safety.

Concomitant use with nitrates or riociguat is an absolute contraindication because of risk of life‑threatening hypotension.

Patients with unstable cardiac disease, recent myocardial infarction or stroke, severe hypotension, or conditions where sexual activity is inadvisable should avoid PDE5 inhibitors.

Elderly patients and those with significant liver or kidney impairment require lower starting doses and closer monitoring.

• Absolute Contraindications: Concurrent nitrates, riociguat, known allergy to sildenafil or tadalafil.
• Relative Contraindications: Severe hepatic or renal impairment, recent MI/stroke, unstable angina, retinitis pigmentosa.

Activities To Limit (Driving, Workplace Safety)

Because dizziness and visual changes are reported side effects, avoid driving or operating heavy machinery until you know how the tablet affects you.

Avoid tasks with high fall risk or dangerous machinery for several hours after dosing, especially if you experience lightheadedness.

Avoid recreational nitrates such as amyl nitrite (“poppers”) which can cause severe hypotension when taken with PDE5 inhibitors.

• Emergency Signs: Seek urgent care for priapism, sudden vision loss, chest pain, severe dizziness, or fainting.
• Red-Flag Symptoms Checklist: Prolonged erection >4 hours, sudden decreased vision, sudden hearing loss, syncope or severe hypotension.

Dosage & Adjustments

General Regimen (DIN References)

Marketed online formulations of Sildalis are typically 100 mg sildenafil plus 20 mg tadalafil per tablet with dosing guidance of one tablet 30–60 minutes before sexual activity, not more than once in 24 hours.

There is no Health Canada DIN for Sildalis, so prescribers should document when patients bring an imported product and treat it clinically as a combination of sildenafil and tadalafil.

Special Cases (Elderly, Comorbidities)

Older adults have greater sensitivity to hypotension and should start conservatively with pharmacist or prescriber oversight.

When combining with alpha-blockers, antihypertensives or multiple cardiac medications, blood pressure monitoring is essential.

Because Sildalis lacks formal dose-ranging studies, dose adjustments must mirror individual sildenafil and tadalafil guidance and be individualized.

User Testimonials

Positive Reports From Canadian Patients

Forum posts and anecdotal reports commonly praise improved erection rigidity and a longer window of effect attributed to tadalafil’s duration.

Many urban patients note quick access to pharmacy consultation and easy substitution with licensed sildenafil or tadalafil products when needed.

Commonly reported side effects in user threads include headaches, flushing and back pain, aligning with known adverse events for the individual drugs.

Common Challenges In Forums

Rural users often report concerns about authenticity when ordering from overseas suppliers and a reliance on online reviews.

Inconsistent tablet appearance, variable onset times linked to meals, and uncertainty about interactions are frequent complaints.

• Pros From Reports: Perceived stronger effect, longer action window, cost savings online.
• Cons From Reports: Side effects, provenance worries, lack of regulated DIN and pharmacist oversight.

• Online Vendor Checklist: Verify pharmacy licence, readable contact info, country of origin, batch/expiry details, and positive independent reviews.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Canadian pharmacy chains dispense licensed sildenafil or tadalafil products with Health Canada DINs rather than unregistered Sildalis tablets.

Pharmacists at Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs can confirm provincial coverage options and recommend safe alternatives.

In our online pharmacy, sildalis is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

Branded products such as Viagra and Cialis generally cost more than generics dispensed by Canadian pharmacies.

Online suppliers based abroad may advertise lower prices but lack Health Canada oversight and a DIN, increasing quality risk.

• Verified-Pharmacy Checklist: Ask for licence number, confirm Canadian phone/address, check for DIN on products, and consult your provincial pharmacist if unsure.

What’s Inside & How It Works

Ingredients Overview

Sildalis tablets combine sildenafil citrate and tadalafil, commonly in marketed tablets of 100 mg sildenafil plus 20 mg tadalafil.

Each ingredient is a phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction.

• Sildenafil Citrate: Shorter-acting PDE5 inhibitor that increases cGMP to promote penile blood flow.
• Tadalafil: Longer-acting PDE5 inhibitor with similar mechanism and longer duration.

Mechanism Basics

Both sildenafil and tadalafil inhibit PDE5, which raises cyclic guanosine monophosphate (cGMP) levels in penile tissue and facilitates erection when sexually stimulated.

Sildenafil typically acts within 30–60 minutes and lasts about 4–6 hours, while tadalafil has a duration up to 36 hours.

Combining both may increase efficacy for some patients but also raises cumulative adverse event risk, such as headaches and muscle or back pain commonly associated with tadalafil.

• Onset/Duration Comparison: Sildenafil — onset 30–60 minutes, duration ~4–6 hours; Tadalafil — onset similar, duration up to 36 hours.
• Monitoring Checklist: Track headaches, visual changes, priapism, blood pressure changes and back or muscle pain.

Main Indications

Approved Uses In Canada

There is no Health Canada–approved Sildalis product or DIN for the fixed-dose combination tablet.

Individual components are approved in Canada for erectile dysfunction under their respective product monographs when sold with a DIN.

• Sildenafil: Approved for erectile dysfunction and, in other formulations, pulmonary arterial hypertension (distinct product).
• Tadalafil: Approved for erectile dysfunction and other indications per product monograph.

Off-Label Uses By Canadian Physicians

Physicians may conceptually discuss combining PDE5 inhibitors in complex cases, but unsupervised use of an imported fixed-dose combination is not commonly recommended.

Supervised combination therapy would require specialist oversight and clear documentation due to absent pharmacokinetic and safety studies for the fixed-dose product.

• Clinical Considerations Checklist: Confirm cardiovascular stability, review full medication list, consider specialist referral for refractory ED, and prefer licensed alternatives when possible.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

High-fat meals may delay absorption of sildenafil and therefore slow onset; plan dosing around big meals.

Alcohol increases the risk of dizziness and hypotension when taken with PDE5 inhibitors and should be consumed in moderation or avoided on dosing days.

Caffeine interactions are minor but can increase jitteriness if combined with stimulants.

• Food Guidance: Avoid heavy, fatty meals immediately before dosing; limit alcohol to moderate amounts.

Drug Conflicts (Health Canada Database)

Concurrent nitrates and riociguat are strictly contraindicated with PDE5 inhibitors and pose a severe hypotension risk.

Strong CYP3A4 inhibitors (certain antifungals and some HIV medications) can increase PDE5 inhibitor levels and require dose adjustment or avoidance.

• High-Risk Drug List: Nitrates, riociguat, strong CYP3A4 inhibitors, multiple antihypertensives and alpha-blockers used without monitoring.
• What To Tell Your Pharmacist: Provide a complete medication list including over-the-counter drugs, recreational nitrate use, herbal products and recent prescriptions.

Latest Evidence & Insights

Canadian Studies And Surveillance Data

There are no Health Canada approvals or controlled Canadian trials for the sildenafil+tadalafil fixed‑dose combination known as Sildalis.

Surveillance data specific to the combination are limited, and pharmacovigilance reports are sparse compared with individual agents.

International Research And Case Reports

Internationally, case reports and pharmacovigilance notes raise concerns about additive adverse effects when combining PDE5 inhibitors without formal study.

Published efficacy and safety data exist for sildenafil and tadalafil as individual agents but not for their fixed-dose combination.

Evidence Gaps And Safety Signals

Key gaps include a lack of dose-ranging studies, PK/PD interaction data for the combined product, and long-term safety evidence for repeated use of the fixed-dose tablet.

Alternative Choices

Comparable Medicines (Viagra, Cialis, Levitra)

Licensed alternatives in Canada include sildenafil (Viagra and generics), tadalafil (Cialis and generics), and vardenafil (Levitra).

These options have established safety profiles, product monographs and Health Canada DINs when dispensed through regulated pharmacies.

Pros/Cons Checklist For Alternatives

• Pros: Regulated dosing, known interaction profiles, provincial reimbursement possible for approved products.
• Cons: Single-agent duration that may not match perceived “dual action” marketing of Sildalis.

When To Consult A Specialist

Refer to a urologist or sexual medicine specialist for refractory erectile dysfunction, complex cardiovascular disease, or when considering off-label combination strategies.

Regulation Snapshot

Health Canada Approval And DIN Requirements

Sildalis as a fixed-dose sildenafil+tadalafil product has no Health Canada DIN and is not registered as a combination with major regulators per available data.

In Canada, prescription drugs require a DIN and product monograph to be sold through regulated supply chains; unregistered products lack this oversight.

Provincial Reimbursement And Pharmacy Policies

Provincial drug plans reimburse approved DIN products per each formulary’s rules; unregistered Sildalis would not qualify for routine reimbursement.

Community pharmacists follow Health Canada and provincial college guidance when advising on safety and sourcing alternatives.

Online Import Legality And Cross-Border Notes

Cross-border or direct importation from overseas vendors can risk unregulated product quality and may contravene import rules; confiscation is possible.

• Legal Checklist For Import: Check for Health Canada DIN, confirm supplier licence, avoid products with missing batch/expiry information, and consult a pharmacist before use.

FAQ

Is Sildalis Legal And Approved In Canada?

No.

Sildalis does not have a Health Canada–approved DIN and is not an officially registered fixed‑dose combination in Canada.

Can I Get It At Shoppers/Rexall/Jean Coutu?

Typically not as Sildalis itself.

Canadian chains dispense licensed sildenafil or tadalafil with DINs and will advise against using unregistered combination tablets from unverified sources.

What If I Bought Sildalis Online?

Bring the product and packaging to your pharmacist for inspection and document provenance before using.

If the tablet provenance is unclear, avoid taking it and consult your prescriber to discuss risks such as interactions and dosing.

• Steps If You Bought It Online: Save packaging, bring product to the pharmacist, do not combine with nitrates, report unexpected adverse events, and consider switching to licensed alternatives.

Will Provincial Plans Cover It?

Unlikely without a DIN; check specific formularies with your pharmacist for covered alternatives and reimbursement rules.

Guidelines For Proper Use

Canadian Pharmacist Recommendations

Request a medication review before using any unregistered combination and provide a full list of current prescriptions and supplements.

Pharmacists will check cardiovascular risk, drug interactions and suggest licensed sildenafil or tadalafil products when appropriate.

Provincial Health Authority Guidance

Follow provincial public health and formulary rules when sourcing erectile dysfunction medication and document any imported product use in the patient record.

Practical Checklist For Patients

• Verify a prescription with a Canadian prescriber where possible.
• Bring a complete medication list to appointments and to your pharmacist.
• Do not use with nitrates or riociguat.
• Start with the lowest effective dose and monitor blood pressure.
• Avoid heavy fatty meals and limit alcohol on dosing days.
• Store tablets below 30°C and away from humidity.
• Seek emergency care for priapism or sudden vision or hearing changes.
• Keep records for any provincial drug plan queries.

Delivery Across Canada (English)